Concepedia
Statistics
Publications
5
Citations
385
H-Index
Active since
1993
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Peter Ingold is an author at Novartis (Switzerland) specializing in osteoporosis, bone metabolism, and health sciences.
Top concepts
HealthOsteoporosisBone MetabolismMedicineAromataseRadiologyPhysiologyBone HealthEngineeringBiomechanics
Publications per year
1993–2018
Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity
Christoph Walker, Martin Kägi, Peter Ingold et al. · Clinical & Experimental Allergy · 1993 · 105 citations
Long-Term Protective Effects of Zoledronic Acid on Cancellous and Cortical Bone in the Ovariectomized Rat
Jürg A. Gasser, Peter Ingold, Andrea Venturiere et al. · Journal of Bone and Mineral Research · 2007 · 102 citations · Full text
Interleukin‐17A Inhibition Diminishes Inflammation and New Bone Formation in Experimental Spondyloarthritis
Melissa N. van Tok, Leonie M. van Duivenvoorde, Ina Krämer et al. · Arthritis & Rheumatology · 2018 · 96 citations
Noninvasive monitoring of changes in structural cancellous bone parameters with a novel prototype micro-CT
Jürg A. Gasser, Peter Ingold, Konstantina Grosios et al. · Journal of Bone and Mineral Metabolism · 2005 · 52 citations
Mechanobiology, Bone Imaging, Engineering +13
A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats
Jürg A. Gasser, Jonathan R. Green, Victor Shen et al. · Bone · 2006 · 30 citations
Zoledronic Acid, Bone Health, Aromatase Inhibition +13
1–5 of 5